Efficacy of spesolimab for the treatment of GPP flares across prespecified patient subgroups in the Effisayil 1 study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s121, 2023. DOI: 10.25251/skin.7.supp.121. Disponível em: https://skin.dermsquared.com/skin/article/view/2015. Acesso em: 8 jun. 2025.